000			01894 a2200493 4500
005			20250514051252.0
264		0	_c20021122
008			200211s 0 0 eng d
022			_a0002-9440
024	7		_a10.1016/S0002-9440(10)64467-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aHu, Limin
245	0	0	_aVascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. _h[electronic resource]
260			_bThe American journal of pathology _cNov 2002
300			_a1917-24 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntineoplastic Agents, Phytogenic _xtherapeutic use
650	0	4	_aApoptosis
650	0	4	_aAscites _xprevention & control
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aCell Division
650	0	4	_aCombined Modality Therapy
650	0	4	_aEndothelial Growth Factors _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aIntercellular Signaling Peptides and Proteins _ximmunology
650	0	4	_aLymphokines _xantagonists & inhibitors
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNeutralization Tests
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPaclitaxel _xtherapeutic use
650	0	4	_aTumor Cells, Cultured
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aHofmann, Judith
700	1		_aZaloudek, Charles
700	1		_aFerrara, Napoleone
700	1		_aHamilton, Thomas
700	1		_aJaffe, Robert B
773	0		_tThe American journal of pathology _gvol. 161 _gno. 5 _gp. 1917-24
856	4	0	_uhttps://doi.org/10.1016/S0002-9440(10)64467-7 _zAvailable from publisher's website
999			_c12222475 _d12222475